Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant (ASCENT)

NCT03924401 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT03924401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03924401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant (ASCENT)
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 22, 2019
Completion date
March 1, 2027
Enrollment
30 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease